This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Use in Detection of Cancer Recurrence

Jeffrey J. Sorokin, MD; Paul H. Sugarbaker, MD; Norman Zamcheck, MD; Michael Pisick, MD; Herbert Z. Kupchik, PhD; Francis D. Moore, MD

JAMA. 1974;228(1):49-53.

Abstract
A prospective study of 102 patients who had undergone potentially curative operations for colorectal cancer was undertaken to correlate serial carcinoembryonic antigen (CEA) levels with the clinical course. When included in this study, patients selected had no detectable metastatic or recurrent disease. Twelve patients developed sustained elevations in their CEA levels greater than 2.5 ng/ml. Six of these had progressively rising CEA titers, and all developed subsequently recurrent cancer; rising CEA levels were observed 0 to 29 months before cancer recurrence was clinically detected. The six with "stable" elevations and six with transient elevations developed no clinically detectable cancer. Eighty-four patients with CEA levels consistently under 2.5 ng/ml had no evidence of recurrent neoplasms. Two developed second primaries. Serial CEA assays postoperatively help detect recurrent colon cancer in asymptomatic patients. (JAMA 228:49-53, 1974)

Author Affiliations
From the Department of Surgery (Drs. Sugarbaker and Moore), Harvard Medical School and Peter Bent Brigham Hospital, and the Mallory Gastrointestinal and Thorndike Memorial Laboratories, Harvard Medical Unit, Boston City Hospital, the Department of Medicine, Harvard Medical School, and the Department of Pathology, Boston University School of Medicine (Drs. Sorokin, Zamcheck, Pisick, and Kupchik), Boston.

Footnotes
Reprint requests to Mallory Gastrointestinal Laboratory, Boston City Hospital, Boston 02118 (Dr. Zamcheck).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Oestrogen plus progestogen increased coronary heart disease and breast cancer events in postmenopausal women
Lowe
Evid. Based Med. 2002;7:137-137.
FULL TEXT  

Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
Bidart et al.
Clin. Chem. 1999;45:1695-1707.
ABSTRACT | FULL TEXT  

Clinical Value of Carcinoembryonic Antigen: Diagnosis, Prognosis, and Follow-up of Patients With Cancer
Beatty et al.
Arch Surg 1979;114:563-567.
ABSTRACT  

Tests for Carcinoembryonic Antigen: Role in Diagnosis and Management of Cancer
Gold and Freedman
JAMA 1975;234:190-192.
ABSTRACT